News on Phase Forward from BioPortfolio.com http://www.BioPortfolio.com Consolidated Phase Forward news from BioPortfolio.com Wed, 10 Feb 2010 14:59:41 GMT en Phase Forward says ICRS a must for data management markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040568&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040568&THISHREF=http://c.moreover.com/click/here.pl%3fz2538794684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040568&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040568&THISHREF=http://c.moreover.com/click/here.pl%3fz2538794684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOutsourcing Pharma: Phase Forward says ICRS a must for data management markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040559&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040559&THISHREF=http://c.moreover.com/click/here.pl%3fz2538792409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040559&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040559&THISHREF=http://c.moreover.com/click/here.pl%3fz2538792409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOutsourcing Pharma: OctoPlus Announces That Locteron Interim Phase IIb Data Have Been Accepted For Oral And Poster Presentations Ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042797&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042797&THISHREF=http://c.moreover.com/click/here.pl%3fz2539525588%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042797&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042797&THISHREF=http://c.moreover.com/click/here.pl%3fz2539525588%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: OctoPlus Announces That Locteron Interim Phase IIb Data Have Been Accepted for Oral and Poster Presentations ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041365&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041365&THISHREF=http://c.moreover.com/click/here.pl%3fz2539088420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041365&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041365&THISHREF=http://c.moreover.com/click/here.pl%3fz2539088420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: GeoVax Labs Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application fhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040174&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040174&THISHREF=http://c.moreover.com/click/here.pl%3fz2538629221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040174&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040174&THISHREF=http://c.moreover.com/click/here.pl%3fz2538629221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040497&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040497&THISHREF=http://c.moreover.com/click/here.pl%3fz2538771322%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040497&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040497&THISHREF=http://c.moreover.com/click/here.pl%3fz2538771322%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: OctoPlus announces that Locteron interim Phase IIb data have been accepted for oral and poster presentations ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040281&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040281&THISHREF=http://c.moreover.com/click/here.pl%3fz2538687002%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040281&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040281&THISHREF=http://c.moreover.com/click/here.pl%3fz2538687002%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Medicinal chemistry paper related to the discovery of CUDC-101 publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042284&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042284&THISHREF=http://c.moreover.com/click/here.pl%3fz2539372332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042284&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042284&THISHREF=http://c.moreover.com/click/here.pl%3fz2539372332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Ceradyne, Inc. Receives Phase I Award for Next Generation Ceramic Missile Radomeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042074&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042074&THISHREF=http://c.moreover.com/click/here.pl%3fz2539301355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042074&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042074&THISHREF=http://c.moreover.com/click/here.pl%3fz2539301355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039974&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039974&THISHREF=http://c.moreover.com/click/here.pl%3fz2538504112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039974&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039974&THISHREF=http://c.moreover.com/click/here.pl%3fz2538504112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Johns Hopkins Hospital initiates Phase I trial with Neogenix's NPC-1Chttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039913&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039913&THISHREF=http://c.moreover.com/click/here.pl%3fz2538467673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039913&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039913&THISHREF=http://c.moreover.com/click/here.pl%3fz2538467673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: ::: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Anthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039411&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039411&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039411&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039411&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA (AEGiS)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032309&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032309&THISHREF=http://c.moreover.com/click/here.pl%3fz2534595336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032309&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phase%20Forward&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032309&THISHREF=http://c.moreover.com/click/here.pl%3fz2534595336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAEGIS: